Espoo, Finland

Soini Huhta



Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Soini Huhta: Innovator in Pharmaceutical Purification

Introduction

Soini Huhta is a notable inventor based in Espoo, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the purification processes of various compounds. With a total of 4 patents to her name, Huhta's work has had a meaningful impact on the industry.

Latest Patents

Among her latest patents is the invention titled "Quetiapine hemifumarate purification by crystallization." This process involves preparing and purifying crystalline quetiapine hemifumarate through a crystalline salt that is not a salt of fumaric acid. Another significant patent is the "Crystallization process of quetiapine hemifumarate," which details a method for crystallizing or re-crystallizing quetiapine hemifumarate from a mixture of water and a water-soluble alcohol. These innovations showcase her expertise in pharmaceutical chemistry.

Career Highlights

Soini Huhta is currently employed at Fermion Oy, a company known for its focus on pharmaceutical manufacturing. Her role at Fermion has allowed her to apply her innovative ideas and contribute to the development of effective purification methods in the pharmaceutical sector.

Collaborations

Throughout her career, Huhta has collaborated with notable colleagues such as Petteri Rummakko and Arne Grumann. These partnerships have further enhanced her research and development efforts, leading to successful innovations in her field.

Conclusion

Soini Huhta is a distinguished inventor whose work in pharmaceutical purification processes has garnered attention and respect in the industry. Her contributions continue to influence the development of effective pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…